169 related articles for article (PubMed ID: 32678926)
1. Macrophage dysfunction in cystic fibrosis: Nature or nurture?
Turton KB; Ingram RJ; Valvano MA
J Leukoc Biol; 2021 Mar; 109(3):573-582. PubMed ID: 32678926
[TBL] [Abstract][Full Text] [Related]
2. Disease-causing mutations in the cystic fibrosis transmembrane conductance regulator determine the functional responses of alveolar macrophages.
Deriy LV; Gomez EA; Zhang G; Beacham DW; Hopson JA; Gallan AJ; Shevchenko PD; Bindokas VP; Nelson DJ
J Biol Chem; 2009 Dec; 284(51):35926-38. PubMed ID: 19837664
[TBL] [Abstract][Full Text] [Related]
3. Cystic fibrosis transmembrane conductance regulator (CFTR) modulators have differential effects on cystic fibrosis macrophage function.
Zhang S; Shrestha CL; Kopp BT
Sci Rep; 2018 Nov; 8(1):17066. PubMed ID: 30459435
[TBL] [Abstract][Full Text] [Related]
4. Cystic fibrosis transmembrane conductance regulator-independent phagosomal acidification in macrophages.
Haggie PM; Verkman AS
J Biol Chem; 2007 Oct; 282(43):31422-8. PubMed ID: 17724021
[TBL] [Abstract][Full Text] [Related]
5. On the mechanism of gating defects caused by the R117H mutation in cystic fibrosis transmembrane conductance regulator.
Yu YC; Sohma Y; Hwang TC
J Physiol; 2016 Jun; 594(12):3227-44. PubMed ID: 26846474
[TBL] [Abstract][Full Text] [Related]
6. CFTR-dependent defect in alternatively-activated macrophages in cystic fibrosis.
Tarique AA; Sly PD; Holt PG; Bosco A; Ware RS; Logan J; Bell SC; Wainwright CE; Fantino E
J Cyst Fibros; 2017 Jul; 16(4):475-482. PubMed ID: 28428011
[TBL] [Abstract][Full Text] [Related]
7. Emerging Concepts in Defective Macrophage Phagocytosis in Cystic Fibrosis.
Jaganathan D; Bruscia EM; Kopp BT
Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35887098
[TBL] [Abstract][Full Text] [Related]
8. Structural mechanisms for defective CFTR gating caused by the Q1412X mutation, a severe Class VI pathogenic mutation in cystic fibrosis.
Yeh JT; Yu YC; Hwang TC
J Physiol; 2019 Jan; 597(2):543-560. PubMed ID: 30408177
[TBL] [Abstract][Full Text] [Related]
9. Dynamics intrinsic to cystic fibrosis transmembrane conductance regulator function and stability.
Chong PA; Kota P; Dokholyan NV; Forman-Kay JD
Cold Spring Harb Perspect Med; 2013 Mar; 3(3):a009522. PubMed ID: 23457292
[TBL] [Abstract][Full Text] [Related]
10. Burkholderia cenocepacia-induced delay of acidification and phagolysosomal fusion in cystic fibrosis transmembrane conductance regulator (CFTR)-defective macrophages.
Lamothe J; Valvano MA
Microbiology (Reading); 2008 Dec; 154(Pt 12):3825-3834. PubMed ID: 19047750
[TBL] [Abstract][Full Text] [Related]
11. Two cystic fibrosis transmembrane conductance regulator mutations have different effects on both pulmonary phenotype and regulation of outwardly rectified chloride currents.
Fulmer SB; Schwiebert EM; Morales MM; Guggino WB; Cutting GR
Proc Natl Acad Sci U S A; 1995 Jul; 92(15):6832-6. PubMed ID: 7542778
[TBL] [Abstract][Full Text] [Related]
12. CFTR transmembrane segments are impaired in their conformational adaptability by a pathogenic loop mutation and dynamically stabilized by Lumacaftor.
Krainer G; Schenkel M; Hartmann A; Ravamehr-Lake D; Deber CM; Schlierf M
J Biol Chem; 2020 Feb; 295(7):1985-1991. PubMed ID: 31882543
[TBL] [Abstract][Full Text] [Related]
13. Elevated Mirc1/Mir17-92 cluster expression negatively regulates autophagy and CFTR (cystic fibrosis transmembrane conductance regulator) function in CF macrophages.
Tazi MF; Dakhlallah DA; Caution K; Gerber MM; Chang SW; Khalil H; Kopp BT; Ahmed AE; Krause K; Davis I; Marsh C; Lovett-Racke AE; Schlesinger LS; Cormet-Boyaka E; Amer AO
Autophagy; 2016 Nov; 12(11):2026-2037. PubMed ID: 27541364
[TBL] [Abstract][Full Text] [Related]
14. Cystic fibrosis transmembrane conductance regulator (CFTR) and renal function.
Stanton BA
Wien Klin Wochenschr; 1997 Jun; 109(12-13):457-64. PubMed ID: 9261986
[TBL] [Abstract][Full Text] [Related]
15. [CFTR and ENaC functions in cystic fibrosis].
Palma AG; Kotsias BA; Marino GI
Medicina (B Aires); 2014; 74(2):133-9. PubMed ID: 24736260
[TBL] [Abstract][Full Text] [Related]
16. Trimethylangelicin promotes the functional rescue of mutant F508del CFTR protein in cystic fibrosis airway cells.
Favia M; Mancini MT; Bezzerri V; Guerra L; Laselva O; Abbattiscianni AC; Debellis L; Reshkin SJ; Gambari R; Cabrini G; Casavola V
Am J Physiol Lung Cell Mol Physiol; 2014 Jul; 307(1):L48-61. PubMed ID: 24816489
[TBL] [Abstract][Full Text] [Related]
17. Localization of cystic fibrosis transmembrane conductance regulator in chloride secretory epithelia.
Denning GM; Ostedgaard LS; Cheng SH; Smith AE; Welsh MJ
J Clin Invest; 1992 Jan; 89(1):339-49. PubMed ID: 1370301
[TBL] [Abstract][Full Text] [Related]
18. Cystic fibrosis transmembrane conductance regulator-mRNA delivery: a novel alternative for cystic fibrosis gene therapy.
Bangel-Ruland N; Tomczak K; Fernández Fernández E; Leier G; Leciejewski B; Rudolph C; Rosenecker J; Weber WM
J Gene Med; 2013; 15(11-12):414-26. PubMed ID: 24123772
[TBL] [Abstract][Full Text] [Related]
19. Local modulation of cystic fibrosis conductance regulator: cytoskeleton and compartmentalized cAMP signalling.
Monterisi S; Casavola V; Zaccolo M
Br J Pharmacol; 2013 May; 169(1):1-9. PubMed ID: 23072488
[TBL] [Abstract][Full Text] [Related]
20. Targeted therapy for cystic fibrosis: cystic fibrosis transmembrane conductance regulator mutation-specific pharmacologic strategies.
Rubenstein RC
Mol Diagn Ther; 2006; 10(5):293-301. PubMed ID: 17022692
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
